These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24188045)

  • 1. Protective immunity against malaria after vaccination.
    de Souza JB
    Parasite Immunol; 2014 Mar; 36(3):131-9. PubMed ID: 24188045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria prevention: from immunological concepts to effective vaccines and protective antibodies.
    Cockburn IA; Seder RA
    Nat Immunol; 2018 Nov; 19(11):1199-1211. PubMed ID: 30333613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding protective immune mechanisms induced by malaria vaccines in the context of clinical trials.
    Dobaño C; Campo JJ
    Hum Vaccin; 2009 Aug; 5(8):562-5. PubMed ID: 19287202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential for recruiting immune responses toward type 1 or type 2 T cell help.
    Golding B; Zaitseva M; Golding H
    Am J Trop Med Hyg; 1994; 50(4 Suppl):33-40. PubMed ID: 8172330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS.
    Bergmann-Leitner ES; Legler PM; Savranskaya T; Ockenhouse CF; Angov E
    Vaccine; 2011 Aug; 29(35):5940-9. PubMed ID: 21722682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity to pre-erythrocytic stage malaria.
    Schwenk RJ; Richie TL
    Trends Parasitol; 2011 Jul; 27(7):306-14. PubMed ID: 21435951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpreting challenge data from early phase malaria blood stage vaccine trials.
    Good MF; Miller LH
    Expert Rev Vaccines; 2018 Mar; 17(3):189-196. PubMed ID: 29382292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending Protection.
    Raja AI; Cai Y; Reiman JM; Groves P; Chakravarty S; McPhun V; Doolan DL; Cockburn I; Hoffman SL; Stanisic DI; Good MF
    Infect Immun; 2016 Aug; 84(8):2274-2288. PubMed ID: 27245410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
    Friesen J; Matuschewski K
    Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.
    Burns JM; Flaherty PR; Nanavati P; Weidanz WP
    Infect Immun; 2004 Oct; 72(10):5605-12. PubMed ID: 15385457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
    Reyes-Sandoval A; Sridhar S; Berthoud T; Moore AC; Harty JT; Gilbert SC; Gao G; Ertl HC; Wilson JC; Hill AV
    Eur J Immunol; 2008 Mar; 38(3):732-41. PubMed ID: 18266272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria vaccines in the eradication era: current status and future perspectives.
    Wilson KL; Flanagan KL; Prakash MD; Plebanski M
    Expert Rev Vaccines; 2019 Feb; 18(2):133-151. PubMed ID: 30601095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force.
    Tyagi RK; Garg NK; Sahu T
    J Control Release; 2012 Aug; 162(1):242-54. PubMed ID: 22564369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Various carrier system(s)- mediated genetic vaccination strategies against malaria.
    Tyagi RK; Sharma PK; Vyas SP; Mehta A
    Expert Rev Vaccines; 2008 May; 7(4):499-520. PubMed ID: 18444895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory issues in immunity to liver and blood-stage malaria.
    Van Braeckel-Budimir N; Kurup SP; Harty JT
    Curr Opin Immunol; 2016 Oct; 42():91-97. PubMed ID: 27351448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral vector vaccines make memory T cells against malaria.
    Reyes-Sandoval A; Harty JT; Todryk SM
    Immunology; 2007 Jun; 121(2):158-65. PubMed ID: 17462077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 43 kDa and 66 kDa, two blood stage antigens induce immune response in Plasmodium berghei malaria.
    Pirta C; Banyal HS
    Indian J Exp Biol; 2014 Aug; 52(8):781-6. PubMed ID: 25141540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein.
    Parra M; Liu X; Derrick SC; Yang A; Molina-Cruz A; Barillas-Mury C; Zheng H; Thao Pham P; Sedegah M; Belmonte A; Litilit DD; Waldmann TA; Kumar S; Morris SL; Perera LP
    PLoS One; 2015; 10(10):e0141141. PubMed ID: 26505634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity against malaria liver stage after vaccination with live parasites.
    Rénia L
    Parasite; 2008 Sep; 15(3):379-83. PubMed ID: 18814710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.